• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肾移植受者接种 3 剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的细胞和体液免疫反应

Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.

机构信息

Medizinische Klinik und Poliklinik III, Nephrologie, Universitätsklinikum, Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

KfH-Nierenzentrum Dresden, Dresden, Germany.

出版信息

Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.

DOI:10.1097/TP.0000000000003903
PMID:34342963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8549130/
Abstract

Supplemental Digital Content is available in the text.

摘要

补充数字内容可在文本中找到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d0/8549130/bf819cb33a77/tp-105-e267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d0/8549130/bf819cb33a77/tp-105-e267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d0/8549130/bf819cb33a77/tp-105-e267-g001.jpg

相似文献

1
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.肾移植受者接种 3 剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的细胞和体液免疫反应
Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.
2
Impact of Kidney Transplantation on Humoral Immunity Against SARS-CoV-2: A Case Series From Belgium.肾移植对针对严重急性呼吸综合征冠状病毒2的体液免疫的影响：来自比利时的病例系列
Transplantation. 2021 Nov 1;105(11):e257-e258. doi: 10.1097/TP.0000000000003910.
3
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients.青少年和年轻成年肾移植受者对 BNT162b2 COVID-19 mRNA 疫苗的血清学反应。
Transplantation. 2021 Nov 1;105(11):e226-e233. doi: 10.1097/TP.0000000000003922.
4
Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients.心脏和胸部移植受者对两剂 SARS-CoV-2 信使 RNA 疫苗 BNT162b2 的体液和 T 细胞应答较差。
Clin Res Cardiol. 2021 Aug;110(8):1142-1149. doi: 10.1007/s00392-021-01880-5. Epub 2021 Jul 9.
5
Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies.肾移植受者对使用 RBD IgG 和中和抗体的 BNT162b2 SARS-CoV-2 mRNA 疫苗的体液反应。
Transplantation. 2021 Nov 1;105(11):e234-e243. doi: 10.1097/TP.0000000000003889.
6
T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients.比利时肾移植受者队列中两剂BNT162b2疫苗后的T细胞和抗体反应
Transplantation. 2021 Oct 1;105(10):e142-e143. doi: 10.1097/TP.0000000000003892.
7
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients.抗代谢药物方案对实体器官移植受者接种 SARS-CoV-2 疫苗后细胞和体液免疫应答的影响。
Immunol Lett. 2024 Aug;268:106886. doi: 10.1016/j.imlet.2024.106886. Epub 2024 Jun 19.
8
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.肾移植受者中 SARS-CoV-2 BNT162b2（tozinameran）疫苗加强接种后体液和细胞免疫受损。
J Clin Invest. 2021 Jul 15;131(14). doi: 10.1172/JCI150175.
9
The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.加强针接种间隔时间对 BNT162b2 疫苗接种的实体器官移植受者体液免疫应答的影响。
Viruses. 2024 May 28;16(6):860. doi: 10.3390/v16060860.
10
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.癌症患者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BNT162b2 mRNA疫苗延迟第二剂的体液免疫和细胞免疫
Cancer Cell. 2021 Nov 8;39(11):1445-1447. doi: 10.1016/j.ccell.2021.10.003. Epub 2021 Oct 12.

引用本文的文献

1
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc Study.混合免疫可预防肾移植受者、透析患者和医务人员接种SARS-CoV-2 mRNA疫苗后的抗体衰减：前瞻性观察性Dia-Vacc研究的9个月数据
Vaccines (Basel). 2024 Jul 19;12(7):801. doi: 10.3390/vaccines12070801.
2
Partial recovery of SARS-CoV-2 immunity after booster vaccination in renal transplant recipients.肾移植受者加强免疫接种后SARS-CoV-2免疫力的部分恢复。
Clin Immunol Commun. 2023 Dec;3:1-5. doi: 10.1016/j.clicom.2022.12.001. Epub 2022 Dec 11.
3
Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients.
第三剂 SARS-CoV-2 疫苗接种后低抗刺突抗体水平与肾移植受者因有症状突破感染而住院之间的关联。
Ann Lab Med. 2024 Jan 1;44(1):64-73. doi: 10.3343/alm.2024.44.1.64. Epub 2023 Sep 4.
4
Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis.肾移植受者中 SARS-CoV-2 疫苗接种的细胞免疫反应：系统评价和荟萃分析。
Front Immunol. 2023 Jul 26;14:1220148. doi: 10.3389/fimmu.2023.1220148. eCollection 2023.
5
The Cellular and Humoral Immune Response to SARS-CoV-2 Messenger RNA Vaccines Is Significantly Better in Liver Transplant Patients Compared with Kidney Transplant Patients.与肾移植患者相比，肝移植患者对严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗的细胞免疫和体液免疫反应明显更好。
Pathogens. 2023 Jul 5;12(7):910. doi: 10.3390/pathogens12070910.
6
Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.评估 mRNA 疫苗在实体器官移植受者中的免疫原性。
Medicina (Kaunas). 2023 Jun 2;59(6):1075. doi: 10.3390/medicina59061075.
7
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant.肾移植患者接种 SARS-CoV-2 mRNA 疫苗加强针可诱导产生针对武汉株的中和抗体和 T 细胞激活，但对奥密克戎变异株的反应较低。
Viruses. 2023 May 9;15(5):1132. doi: 10.3390/v15051132.
8
Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review.肾移植受者额外接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗剂量的有效性、免疫原性和危害：一项系统评价
Vaccines (Basel). 2023 Apr 18;11(4):863. doi: 10.3390/vaccines11040863.
9
Efficacy and safety of booster vaccination against SARS-CoV-2 in dialysis and renal transplant patients: systematic review and meta-analysis.透析和肾移植患者接种 SARS-CoV-2 加强疫苗的疗效和安全性：系统评价和荟萃分析。
Int Urol Nephrol. 2023 Apr;55(4):791-802. doi: 10.1007/s11255-023-03471-x. Epub 2023 Feb 1.
10
Pediatric kidney transplantation during the COVID-19 pandemic.新冠疫情期间的小儿肾移植
World J Clin Cases. 2022 Dec 6;10(34):12494-12499. doi: 10.12998/wjcc.v10.i34.12494.